PLEASANTON, CA—(Marketwired – December 28, 2015) – ZELTIQ®
Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled–cooling technology, today announced the launch of its national advertising campaign that encourages consumers to Fear No Mirror®
with the CoolSculpting® procedure.
“While the CoolSculpting procedure is recognized as the number one non–invasive fat reduction treatment by physicians in the aesthetics space, we realize that many consumers are unfamiliar with our breakthrough treatment,” said Mark Foley, President and Chief Executive Officer of ZELTIQ. “We are excited to build awareness and interest in the marketplace using insights from our direct–to–consumer pilots conducted earlier this year.”
The Fear No Mirror advertising campaign executes on the universal insight of how consumers feel when they see a reflection of themselves, and the insight that people want to be happy with the way they look in clothing. The CoolSculpting procedure allows consumers to love what they see in the mirror and feel more confident.
The national campaign leverages learnings from the successful direct–to–consumer pilot held in 11 U.S. cities: Atlanta, Dallas, Denver, Houston, San Diego, Miami / Ft. Lauderdale, Minneapolis, Philadelphia, Phoenix, Seattle, Washington, DC. CoolSculpting website traffic increased by three times in those markets, and local CoolSculpting providers experienced a significant increase in patient interest and treatments. The multiple channels ZELTIQ plans to leverage include television commercials, radio spots, digital advertising, social media, and public relations. These efforts will be complementary to the significant investment in co–op advertising ZELTIQ has made over the last few years and will continue in 2016.
The CoolSculpting procedure is FDA–cleared. It is available in the United States for the non–invasive treatment of visible fat bulges in the submental area, thigh, abdomen and flank. In other international markets, it is approved for general non–invasive fat reduction. The CoolSculpting procedure results in a noticeable and measurable reduction of fat in the treated areas, and the treated fat is gone for good. Most patients can start to see results as soon as three weeks following treatment, with the most dramatic results occurring over a period of one to three months. Every patient is unique, so patients are encouraged to talk to their physicians about a customized treatment plan as part of the initial consultation. Additional treatments in the same or multiple areas may enhance the desired aesthetic effect.Â
The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.Â
About the CoolSculpting
®
Procedure
The CoolSculpting procedure is a non–surgical, clinically proven procedure that selectively reduces unwanted fat using a patented cooling technology. The CoolSculpting procedure is cleared by the FDA. The CoolSculpting procedure works by gently cooling targeted fat cells in the body to induce a natural, controlled elimination of fat cell without affecting surrounding tissue, and the treated fat cells are gone for good. Millions of CoolSculpting treatments have been performed by nearly 4,000 CoolSculpting systems in over 70 countries. Market research indicates a 93% customer satisfaction rate with the CoolSculpting procedure. The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.
Be sure to follow CoolSculpting on Facebook, Twitter, Pinterest and YouTube.
About ZELTIQ
®
Aesthetics, Inc.
ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled–cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.